Study finds the SARS-CoV-2 virus can infect the inner ear
Many COVID-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also […]
» Read moreHome »
HSE University researchers assessed the effectiveness of the T-cell immune response to 11 variants of SARS-CoV-2. The researchers used their […] A recent study in the field of fluid analysis reveals a diverse set of strategies utilized by alpha and beta […] With tens of millions of people worldwide having been infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing […] Iain Chapple, University of Birmingham, England, presented the oral session "Longitudinal Serological and Vaccination Responses to SARS-COV-2 in Dental Professionals" […] Researchers in the United States have provided a high-resolution description of the viral dynamics involved in acute infection with severe […] Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 […] Since its emergence in Wuhan, China, in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of […] The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic emerged in late 2019 in Wuhan, China, and has led to […] Amidst the continued surge of coronavirus disease (COVID-19) cases, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccination […]
Immune response to SARS-CoV-2 variants investigated
SARS-CoV-2 variants of concern employ different strategies of antibody escape
How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms
SARS-COV-2 infection leads to neutralizing and protective serological responses in over 70% of DPs
High individual-level variability in SARS-CoV-2 shedding may explain superspreading
Study highlights the importance of T cell cross reactivity in stopping severe COVID-19 infections
SARS-CoV-2 B.1.1.420 and B.1.617.1 immune escape variants reported in France
Single dose of J&J's Ad26.COV2.S vaccine effective against SARS-CoV-2 including in South Africa variant
Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks
